Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
Clinical trial NCT02251067 · COMPLETED
Trial details
- NCT number
- NCT02251067
- Sponsor
- Vascular Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2017-03-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.